<DOC>
	<DOCNO>NCT02195089</DOCNO>
	<brief_summary>The purpose study determine efficacy safety BLS-ILB-E710c fertile woman Cervical Intraepithelial Neoplasia ( CIN3 ) .</brief_summary>
	<brief_title>Efficacy Safety Study BLS_ILB_E710c Fertile Women With Cervical Intraepithelial Neoplasia ( CIN3 )</brief_title>
	<detailed_description>This study see regression rate Cervical Intraepithelial Neoplasia ( CIN3 ) see inducement Cytotoxic T Lymphocyte . The First treatment group administer BLS-ILB-E710c 500mg 8 week follow 1 week observation The Second treatment group administer BLS-ILB-E710c 1000mg 8 week follow 1 week observation The Third treatment group administer BLS-ILB-E710c 1500mg 8 week follow 1 week observation The fourth treatment group administer BLS-ILB-E710c Optimum dose 8 week follow 8 week observation</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Premenopausal patient age 20 50 . Patients cervical intraepithelial neoplasia 3 ( CIN3 ) . Only infection HPV type 16 . Patients Capable observation lesion Colposcopy biopsy . Be informed nature study give write informed consent . Be agree contraception study White Blood Cell Count ( WBC ) 4thous/ul , Hemoglobin 9.0g/dL Platelet 150thous/uL ANC ( Absolute Neutrophil Count ) 1,500 /mm^3 Normal EKG ( Electrocardiography ) AST/ALT : 2.5 time less normal range Autoimmune Disease Prohibited drug ( Therapy ) bring immunosuppressive . Patient medical history hypersensitivity Food contain Lactic acid bacteria Lactic acid bacteria medication . Patient Acute illness ( ex . Acute Appendicitis , Myocardial infarction , Hemorrhage , meningitis etc . ) Investigational product within three month start drug administration patient treated test drug . Patient Chronic pancreatitis currently Patients diagnosed acute pancreatitis . Organopathy Patient Inflammatory intestineÂ·bowel disease , gastrointestinal tumor , ulcer , bleeding , perforation etc . Pregnant lactate woman Patient HBV HCV infection ( except Asymptomatic ) Patient Investigator judge Deemed inappropriate researcher judge patient</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Treatment Cervical Intraepithelial Neoplasia ( CIN3 )</keyword>
</DOC>